Can we identify cystic fibrosis from skeletal remains? A proposed differential diagnosis

2020 ◽  
Author(s):  
Melanie M. Beasley ◽  
Clare K. Remy
PEDIATRICS ◽  
1962 ◽  
Vol 30 (6) ◽  
pp. 1018-1018

Cystic Fibrosis—NCFRF. 16 mm., color, sound, showing time 32 minutes. Produced in 1961 by Samuel L. Schulman for the National Cystic Fibrosis Research Foundation, medical supervision by Giulio J. Barbero, M.D. Philadelphia. Procurable on purchase from National Cystic Fibrosis Research Foundation, 521 Fifth Avenue, New York City 17. Procurable on loan from American Medical Association, Motion Picture Library, 535 N. Dearborn Street, Chicago 10. This film has been prepared to aid physicians in making a correct diagnosis and to instruct them in the techniques currently being used to prolong life in cases of cystic fibrosis. Following the introductoy remarks there is a good discussion of the presenting symptoms, the differential diagnosis, the multiple system involvement, hereditary aspects, therapy, and prognosis. The film brings out well the panexocrine involvement, the clinical variability, and the fact that the disease is not an all or none phenomenon but rather a disease of all grades of severity and is a disease in which no single test is applicable to the exclusion of others. The diagrams and patient demonstrations are good. Perhaps too much review of older methods of therapy and diagnosis is given, but this serves as a background for the newer recommended procedures. More emphasis could have been given to the tremendous burden, both financial and emotional, this disease is on parents. This is an excellent instructive film and it emphasizes the many problems of cystic fibrosis as related to the diagnostic tools available and to forms of therapy. The photography and sound are satisfactory. It is recommended for pediatricians, general practitioners, house staff, and medical students.


2014 ◽  
Author(s):  
Michael J Stephen

Cystic fibrosis (CF) is an autosomal recessive disease characterized by an elevated sweat chloride level, diffuse bronchiectasis, and pancreatic exocrine deficiency. It is the most common lethal inherited disease in whites. Most patients present at birth or early childhood, although later diagnoses are not infrequent. Once CF was uniformly fatal at an early age, but advances in nutrition, airway clearance, and infection management have led to an average survival of 37 years. The newest aspect of care is the advent of protein modulators, which may increase life expectancy even further. This chapter discusses the epidemiology, genetics, pathophysiology and pathogenesis, diagnosis, differential diagnosis, and treatment of CF. The definition, epidemiology, etiology, pathogenesis, diagnosis, management, and prognosis of non-CF bronchiectasis are also covered. Figures illustrate normal and abnormal CF transmembrane conductance regulators, the vicious cycle hypothesis of lung injury, rates of respiratory germs by age, the diagnosis of CF, the therapeutics pipeline for CF, forced expiratory volume in 1 second lung function percent predicted versus body mass index, and the median predicted survival age of patients with CF. A chest x-ray and chest computed tomographic scan of CF are also provided. Tables outline the most common CF mutations in 2011, class mutations of CF, a mnemonic for acute exacerbations of CF, the diagnosis of CF-related diabetes in a stable patient, sweat test values, and the differential diagnosis of bronchiectasis.This chapter contains 9 highly rendered figures, 6 tables, 143 references, 1 teaching slide set, and 5 MCQs.


PEDIATRICS ◽  
1949 ◽  
Vol 3 (5) ◽  
pp. 645-650
Author(s):  
WAYNE H. DANIELSON ◽  
EDWARD L. BINKLEY ◽  
HAROLD D. PALMER

The absorption of vitamin A from oily and aqueous media has been studied in infants and children with cystic fibrosis of the pancreas and idiopathic celiac disease. Patients with cystic fibrosis of the pancreas can absorb vitamin A acetate and vitamin A alcohol when it is given to them in an aqueous dispersion. The vitamin A acetate curves rose above the vitamin A alcohol curves in three of four patients on whom absorption curves were obtained. Vitamin A is absorbed by patients with idiopathic celiac disease only slightly better from an aqueous dispersion of the alcohol than from an oily concentrate of the naturally occurring esters. The poor absorption from an aqueous media by these patients supports the suggestion that the defect in absorption in this disease lies within the intestinal mucosa. The use of the differences in response to oily and aqueous concentrates in the differential diagnosis of the entities of the celiac syndrome is suggested.


2014 ◽  
Author(s):  
Michael J Stephen

Cystic fibrosis (CF) is an autosomal recessive disease characterized by an elevated sweat chloride level, diffuse bronchiectasis, and pancreatic exocrine deficiency. It is the most common lethal inherited disease in whites. Most patients present at birth or early childhood, although later diagnoses are not infrequent. Once CF was uniformly fatal at an early age, but advances in nutrition, airway clearance, and infection management have led to an average survival of 37 years. The newest aspect of care is the advent of protein modulators, which may increase life expectancy even further. This chapter discusses the epidemiology, genetics, pathophysiology and pathogenesis, diagnosis, differential diagnosis, and treatment of CF. The definition, epidemiology, etiology, pathogenesis, diagnosis, management, and prognosis of non-CF bronchiectasis are also covered. Figures illustrate normal and abnormal CF transmembrane conductance regulators, the vicious cycle hypothesis of lung injury, rates of respiratory germs by age, the diagnosis of CF, the therapeutics pipeline for CF, forced expiratory volume in 1 second lung function percent predicted versus body mass index, and the median predicted survival age of patients with CF. A chest x-ray and chest computed tomographic scan of CF are also provided. Tables outline the most common CF mutations in 2011, class mutations of CF, a mnemonic for acute exacerbations of CF, the diagnosis of CF-related diabetes in a stable patient, sweat test values, and the differential diagnosis of bronchiectasis.This chapter contains 9 highly rendered figures, 6 tables, 143 references, 1 teaching slide set, and 5 MCQs.


PEDIATRICS ◽  
1970 ◽  
Vol 45 (5) ◽  
pp. 857-861
Author(s):  
Ordean L. Torstenson ◽  
G. Bennett Humphrey ◽  
J. Roger Edson ◽  
Warren J. Warwick

Three patients are discussed who presented with hemorrhagic diatheses who were subsequently diagnosed as having cystic fibrosis. Their prolonged prothrombin times and low levels of vitamin K-dependent clotting factors were due to vitamin K deficiency. In two patients we believe that the vitamin K deficiency was principally due to malabsorption caused by cystic fibrosis. In the third patient, malabsorption, diarrhea, antibiotic therapy, and low dietary intake all played a part in the development of vitamin K deficiency. Cystic fibrosis should be included in the differential diagnosis of patients under 1 year of age presenting with a bleeding tendency.


2010 ◽  
Vol 42 ◽  
pp. S364
Author(s):  
A. Casale ◽  
N. Amato ◽  
S. De Santis ◽  
V. Chiaro ◽  
V. Terlizzi ◽  
...  

PEDIATRICS ◽  
1984 ◽  
Vol 73 (6) ◽  
pp. 877-877
Author(s):  
BERYL J. ROSENSTEIN

To the Editor.— I read with interest the article by Lane and colleagues1 in which they described a fatal intracranial hemorrhage in a normal infant secondary to vitamin K deficiency. In their patient, vitamin K deficiency was attributed to lack of newborn prophylaxis, with breast-feeding and antibiotic administration as possible contributing factors. It is important to point out that a bleeding disorder can be the presenting manifestation of cystic fibrosis during the first year of life and that this possibility needs to be considered in the differential diagnosis in all infants with evidence of vitamin K deficiency.


2007 ◽  
Vol 37 (6) ◽  
pp. 592-595 ◽  
Author(s):  
Andrey Morozov ◽  
Kimberly E. Applegate ◽  
Shanaree Brown ◽  
Michelle Howenstine

Asthma ◽  
2014 ◽  
pp. 21-31
Author(s):  
Paul A. Greenberger

Allergic bronchopulmonary aspergillosis (ABPA), a disease that complicates asthma and cystic fibrosis, is in the differential diagnosis of pulmonary infiltrates, peripheral blood or sputum eosinophilia, elevated total serum immunoglobulin E concentration, and bronchiectasis, any or all of which may occur in patients with established asthma. ABPA is one of the most important comorbid, coexisting subtypes of asthma because it results in irreversible lung destruction and may convert intermittent or persistent mild asthma into persistent severe asthma. The fact that the treatment of choice to clear pulmonary infiltrates and sputum eosinophilia is an oral steroid but not antifungal therapy remains true after 50 years of attempts to improve our understanding and treatment of ABPA. It remains to be established whether monoclonal antibodies will contribute to meaningful improvement in management of patients, or what combination therapy will be optimum instead of relying on oral glucocorticoids. Certainly, innovative, safe, and effective approaches to treatment are needed to decrease the harmful impact that untreated or inadequately treated ABPA can have on patients with asthma.


Sign in / Sign up

Export Citation Format

Share Document